Armistice Capital

company

About

Armistice Capital is a global, value-oriented and event-driven hedge fund focused primarily on the health care and consumer sector.

Details

Operating Status
Active
Investor Type
Hedge Fund

Investments

Number of Investments
Number of Lead Investments
4
2
Armistice Capital has made 4 investments. Their most recent investment was on Dec 5, 2022, when Karyopharm Therapeutics raised $165M.
Date Company Name
Round Money Raised Industry Lead Investor
Post-IPO Equity $165M Health Care
Jul 7, 2022 Provention Bio
Post-IPO Equity $60M Biotechnology Yes
Mar 4, 2022 Eyenovia
Post-IPO Equity $15M Biotechnology Yes
Post-IPO Equity €12.50M Biotechnology